Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 27.22

+2.8%

Feb 6 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margaret foley who wrote (19)	5/26/1998 10:22:00 AM
From: Anthony Wong	Read Replies (1) of 1722

Margaret, from what I read from this and earlier news articles about this Indian company, is that they claimed they are using a "new process" of making the compound. It is apparent that there is no patent protection in SOME countries where patents and intellectual rights are not respected, e.g. there are 4 companies in China making a generic version of Prozac. No news on how Pfizer is dealing with this situation (in India).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next